ARKEMA (AKE.PA) Fundamental Analysis & Valuation

EPA:AKE • FR0010313833

Current stock price

50.95 EUR
-2.5 (-4.68%)
Last:

This AKE.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. AKE.PA Profitability Analysis

1.1 Basic Checks

  • In the past year AKE was profitable.
  • In the past year AKE had a positive cash flow from operations.
  • Each year in the past 5 years AKE has been profitable.
  • In the past 5 years AKE always reported a positive cash flow from operatings.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

1.2 Ratios

  • With a Return On Assets value of 0.27%, AKE is not doing good in the industry: 62.86% of the companies in the same industry are doing better.
  • AKE has a worse Return On Equity (0.57%) than 64.29% of its industry peers.
  • AKE has a Return On Invested Capital (1.90%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for AKE is below the industry average of 6.99%.
Industry RankSector Rank
ROA 0.27%
ROE 0.57%
ROIC 1.9%
ROA(3y)1.76%
ROA(5y)4.56%
ROE(3y)3.55%
ROE(5y)8.83%
ROIC(3y)2.66%
ROIC(5y)4.13%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • AKE has a worse Profit Margin (0.43%) than 61.43% of its industry peers.
  • AKE's Profit Margin has declined in the last couple of years.
  • The Operating Margin of AKE (4.63%) is comparable to the rest of the industry.
  • AKE's Operating Margin has declined in the last couple of years.
  • AKE has a worse Gross Margin (17.80%) than 74.29% of its industry peers.
  • AKE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.63%
PM (TTM) 0.43%
GM 17.8%
OM growth 3Y-28.32%
OM growth 5Y-8.39%
PM growth 3Y-62.59%
PM growth 5Y-35.51%
GM growth 3Y-7.29%
GM growth 5Y-1.94%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

4

2. AKE.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AKE is destroying value.
  • Compared to 1 year ago, AKE has less shares outstanding
  • Compared to 5 years ago, AKE has less shares outstanding
  • The debt/assets ratio for AKE is higher compared to a year ago.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • AKE has an Altman-Z score of 1.71. This is a bad value and indicates that AKE is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.71, AKE is not doing good in the industry: 68.57% of the companies in the same industry are doing better.
  • AKE has a debt to FCF ratio of 13.85. This is a negative value and a sign of low solvency as AKE would need 13.85 years to pay back of all of its debts.
  • AKE has a Debt to FCF ratio of 13.85. This is comparable to the rest of the industry: AKE outperforms 45.71% of its industry peers.
  • A Debt/Equity ratio of 0.56 indicates that AKE is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.56, AKE is in line with its industry, outperforming 44.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 13.85
Altman-Z 1.71
ROIC/WACC0.43
WACC4.42%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 2.13 indicates that AKE has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.13, AKE is in the better half of the industry, outperforming 67.14% of the companies in the same industry.
  • A Quick Ratio of 1.63 indicates that AKE should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.63, AKE is in the better half of the industry, outperforming 75.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.63
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

3

3. AKE.PA Growth Analysis

3.1 Past

  • AKE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -47.50%.
  • The Earnings Per Share has been decreasing by -3.31% on average over the past years.
  • The Revenue has decreased by -4.99% in the past year.
  • Measured over the past years, AKE shows a small growth in Revenue. The Revenue has been growing by 2.84% on average per year.
EPS 1Y (TTM)-47.5%
EPS 3Y-34.91%
EPS 5Y-3.31%
EPS Q2Q%-66.14%
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y-7.75%
Revenue growth 5Y2.84%
Sales Q2Q%-7.39%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.99% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 2.68% on average over the next years.
EPS Next Y14.19%
EPS Next 2Y16.67%
EPS Next 3Y15.04%
EPS Next 5Y11.99%
Revenue Next Year0.25%
Revenue Next 2Y1.77%
Revenue Next 3Y2.13%
Revenue Next 5Y2.68%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

8

4. AKE.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.82, the valuation of AKE can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 85.71% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.73, AKE is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 10.35, the valuation of AKE can be described as reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 88.57% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.72. AKE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.82
Fwd PE 10.35
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • AKE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AKE is cheaper than 90.00% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 82.86% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.78
EV/EBITDA 5.1
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • AKE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as AKE's earnings are expected to grow with 15.04% in the coming years.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y16.67%
EPS Next 3Y15.04%

7

5. AKE.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 6.40%, AKE is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.38, AKE pays a better dividend. On top of this AKE pays more dividend than 94.29% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, AKE pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.4%

5.2 History

  • On average, the dividend of AKE grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years4
Div Non Decr Years4
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 697.44% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
  • The dividend of AKE is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP697.44%
EPS Next 2Y16.67%
EPS Next 3Y15.04%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

AKE.PA Fundamentals: All Metrics, Ratios and Statistics

ARKEMA

EPA:AKE (3/19/2026, 7:00:00 PM)

50.95

-2.5 (-4.68%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners57.22%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap3.88B
Revenue(TTM)9.07B
Net Income(TTM)39.00M
Analysts71.82
Price Target63.38 (24.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.4%
Yearly Dividend3.59
Dividend Growth(5Y)10.37%
DP697.44%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-24.85%
Min EPS beat(2)-39.37%
Max EPS beat(2)-10.34%
EPS beat(4)0
Avg EPS beat(4)-16.25%
Min EPS beat(4)-39.37%
Max EPS beat(4)-6.61%
EPS beat(8)2
Avg EPS beat(8)-8.47%
EPS beat(12)5
Avg EPS beat(12)-4.27%
EPS beat(16)9
Avg EPS beat(16)3.1%
Revenue beat(2)1
Avg Revenue beat(2)0.01%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)1.2%
Revenue beat(4)1
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.2%
Revenue beat(8)2
Avg Revenue beat(8)-0.43%
Revenue beat(12)3
Avg Revenue beat(12)-1.01%
Revenue beat(16)7
Avg Revenue beat(16)-0.03%
PT rev (1m)2.19%
PT rev (3m)-2.44%
EPS NQ rev (1m)-20.75%
EPS NQ rev (3m)-39.4%
EPS NY rev (1m)-2.04%
EPS NY rev (3m)-10.14%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)-0.45%
Revenue NY rev (1m)-1.17%
Revenue NY rev (3m)-1.52%
Valuation
Industry RankSector Rank
PE 11.82
Fwd PE 10.35
P/S 0.43
P/FCF 11.78
P/OCF 3.89
P/B 0.57
P/tB 2.11
EV/EBITDA 5.1
EPS(TTM)4.31
EY8.46%
EPS(NY)4.92
Fwd EY9.66%
FCF(TTM)4.33
FCFY8.49%
OCF(TTM)13.11
OCFY25.73%
SpS119.22
BVpS89.97
TBVpS24.14
PEG (NY)0.83
PEG (5Y)N/A
Graham Number93.41
Profitability
Industry RankSector Rank
ROA 0.27%
ROE 0.57%
ROCE 3.5%
ROIC 1.9%
ROICexc 2.33%
ROICexgc 4.77%
OM 4.63%
PM (TTM) 0.43%
GM 17.8%
FCFM 3.63%
ROA(3y)1.76%
ROA(5y)4.56%
ROE(3y)3.55%
ROE(5y)8.83%
ROIC(3y)2.66%
ROIC(5y)4.13%
ROICexc(3y)3.19%
ROICexc(5y)5.03%
ROICexgc(3y)6.48%
ROICexgc(5y)9.7%
ROCE(3y)4.96%
ROCE(5y)7.74%
ROICexgc growth 3Y-32.65%
ROICexgc growth 5Y-8.51%
ROICexc growth 3Y-33.65%
ROICexc growth 5Y-10.69%
OM growth 3Y-28.32%
OM growth 5Y-8.39%
PM growth 3Y-62.59%
PM growth 5Y-35.51%
GM growth 3Y-7.29%
GM growth 5Y-1.94%
F-Score6
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 13.85
Debt/EBITDA 3.02
Cap/Depr 79.71%
Cap/Sales 7.37%
Interest Coverage 17.5
Cash Conversion 79.25%
Profit Quality 843.59%
Current Ratio 2.13
Quick Ratio 1.63
Altman-Z 1.71
F-Score6
WACC4.42%
ROIC/WACC0.43
Cap/Depr(3y)89.68%
Cap/Depr(5y)93.13%
Cap/Sales(3y)7.49%
Cap/Sales(5y)7.36%
Profit Quality(3y)365.95%
Profit Quality(5y)238.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-47.5%
EPS 3Y-34.91%
EPS 5Y-3.31%
EPS Q2Q%-66.14%
EPS Next Y14.19%
EPS Next 2Y16.67%
EPS Next 3Y15.04%
EPS Next 5Y11.99%
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y-7.75%
Revenue growth 5Y2.84%
Sales Q2Q%-7.39%
Revenue Next Year0.25%
Revenue Next 2Y1.77%
Revenue Next 3Y2.13%
Revenue Next 5Y2.68%
EBIT growth 1Y-41.5%
EBIT growth 3Y-33.87%
EBIT growth 5Y-5.79%
EBIT Next Year131.92%
EBIT Next 3Y38.79%
EBIT Next 5Y24.49%
FCF growth 1Y-8.61%
FCF growth 3Y-24.55%
FCF growth 5Y-8.39%
OCF growth 1Y-11.06%
OCF growth 3Y-12.65%
OCF growth 5Y-2.21%

ARKEMA / AKE.PA Fundamental Analysis FAQ

What is the fundamental rating for AKE stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.


Can you provide the valuation status for ARKEMA?

ChartMill assigns a valuation rating of 8 / 10 to ARKEMA (AKE.PA). This can be considered as Undervalued.


How profitable is ARKEMA (AKE.PA) stock?

ARKEMA (AKE.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for AKE stock?

The financial health rating of ARKEMA (AKE.PA) is 4 / 10.


Is the dividend of ARKEMA sustainable?

The dividend rating of ARKEMA (AKE.PA) is 7 / 10 and the dividend payout ratio is 697.44%.